FDA Approves New Alzheimer’s Drug, But Not Without Controversy
source: pixabay.com

FDA Approves New Alzheimer’s Drug, But Not Without Controversy

According to an announcement from the US Food and Drug Administration (FDA), the agency has recently approved a new therapy for Alzheimer's disease. While this is a significant moment for…

Continue Reading FDA Approves New Alzheimer’s Drug, But Not Without Controversy
TRIKAFTA Approved for Pediatric Patients with F508del-Mutated Cystic Fibrosis
Myriams-Fotos / Pixabay

TRIKAFTA Approved for Pediatric Patients with F508del-Mutated Cystic Fibrosis

In a news release from June 9, 2021, biotechnology company Vertex Pharmaceuticals, Inc. ("Vertex") shared that its therapy TRIKAFTA (elexacaftor/texacaftor/ivacaftor and ivacaftor) was approved for expanded use. Now, the treatment…

Continue Reading TRIKAFTA Approved for Pediatric Patients with F508del-Mutated Cystic Fibrosis

COVID-19 Long Haulers are Now Being Diagnosed With Conditions like POTS and CFS

It's no secret that COVID-19 can cause lingering symptoms, some of which persist for months. In fact, there is a name for those who deal with the lasting symptoms of…

Continue Reading COVID-19 Long Haulers are Now Being Diagnosed With Conditions like POTS and CFS

A Three-Year-Old Who Was Treated for a Mild Infection Died Four Weeks Later of Cancer in Multiple Organs

Robbie Elliot’s family, who reside in South Shields, England describes him as a perfect boy with a bubbly personality, always giving, and with a special love of music. According to…

Continue Reading A Three-Year-Old Who Was Treated for a Mild Infection Died Four Weeks Later of Cancer in Multiple Organs